All In Biotech

Drug Trial Radar · NCT06383468

A Phase III Study to Evaluate the Efficacy and Safety of AK120 in Patients With Moderate to Severe Atopic Dermatitis

a Randomized Double-blind, Placebo-controlled, Multicenter Phase III Clinical Study to Evaluate the Efficacy and Safety of AK120 in the Treatment of Patients With Moderate to Severe Atopic Dermatitis

Last checked: Nov 19, 2026Latest source record: Apr 25, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingPhase 3. Randomized with 420 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

420

Planned (sponsor's estimate)

Start

Apr 30, 2024

Primary completion

Jan 30, 2025

Study completion Jan 30, 2026

Sponsor

Lead sponsor
AkesoIndustry
Sponsor type
Industry
First posted
Apr 25, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a randomized double-blind, placebo-controlled, multicenter phase III clinical study evaluating the efficacy and safety of AK120 injection in the treatment of patients with moderate to severe atopic dermatitis.

Conditions

  • Atopic Dermatitis

Interventions

  • AK120Drug

    300mg Q2W subcutaneous injection thereafter until week 50.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of subjects who achieved (Eczema Area and Severity Index) EASI-75Time frame: at week 16

Locations

59 sites in 1 country. Site status is shown where the registry gives one.

  • Beijing Friendship Hospital Capital Medical University

    Beijing, Beijing Municipality, China · Recruiting

  • Beijing Luhe Hospital Affiliated to Capital Medical University

    Beijing, Beijing Municipality, China · Recruiting

  • Beijing Tongren Hospital

    Beijing, Beijing Municipality, China · Recruiting

  • Peking University People's Hospital

    Beijing, Beijing Municipality, China · Recruiting

  • Peking University Third Hospital

    Beijing, Beijing Municipality, China · Recruiting

  • Chongqing Three Gorges Medical College Affiliated People's Hospital

    Chongqing, Chongqing Municipality, China · Recruiting

  • Chongqing Traditional Chinese Medicine Hospital

    Chongqing, Chongqing Municipality, China · Recruiting

  • The First Affiliated Hospital of Fujian Medical University

    Fuzhou, Fujian, China · Recruiting

  • The Second Affiliated Hospital of Xiamen Medical College

    Xiamen, Fujian, China · Recruiting

  • Guangdong Provincial People's Hospital

    Guangzhou, Guangdong, China · Recruiting

  • Southern Medical University Dermatology Hospital/Guangdong Provincial Dermatology Hospital

    Guangzhou, Guangdong, China · Recruiting

  • Southern Medical University Southern Hospital

    Guangzhou, Guangdong, China · Recruiting

  • Sun Yat-sen Memorial Hospital, Sun Yat-sen University

    Guangzhou, Guangdong, China · Recruiting

  • The First Affiliated Hospital of Guangzhou Medical University

    Guangzhou, Guangdong, China · Recruiting

  • Zhujiang Hospital of Southern Medical University

    Guangzhou, Guangdong, China · Recruiting

  • Yuebei People's hospital, Guangdong, China

    Shaoguan, Guangdong, China · Recruiting

  • Shunde Hospital of Southern Medical University

    Shunde, Guangdong, China · Recruiting

  • Guangdong Medical University Affiliated Hospital

    Zhanjiang, Guangdong, China · Recruiting

  • The Affiliated Hospital of Guizhou Medical University

    Guiyang, Guizhou, China · Recruiting

  • Hainan General Hospital

    Haikou, Hainan, China · Recruiting

  • Hainan Provincial Fifth People's Hospital

    Haikou, Hainan, China · Recruiting

  • The First Affiliated Hospital of Hainan Medical College

    Haikou, Hainan, China · Recruiting

  • Chengde Medical College Affiliated Hospital

    Chengde, Hebei, China · Recruiting

  • The Second Affiliated Hospital of Xingtai Medical College

    Xingtai, Hebei, China · Recruiting

  • Harbin Medical University Affiliated Second Hospital

    Harbin, Heilongjiang, China · Recruiting

  • Heilongjiang Provincial Hospital

    Harbin, Heilongjiang, China · Recruiting

  • The Second Affiliated Hospital of Henan University of Science and Technology

    Luoyang, Henan, China · Recruiting

  • Renmin Hospital of Wuhan University Hubei General Hospital

    Wuhan, Hubei, China · Recruiting

  • Tongji Hospital

    Wuhan, Hubei, China · Recruiting

  • Changde First People's Hospital

    Changde, Hunan, China · Recruiting

  • Xiangya Hospital of Central South University

    Changsha, Hunan, China · Recruiting

  • The First Affiliated Hospital of South China University

    Hengyang, Hunan, China · Recruiting

  • Inner Mongolia Medical University Affiliated Hospital

    Hohhot, Inner Mongolia, China · Recruiting

  • The First Affiliated Hospital of Bengbu Medical College

    Bengbu, Jiangsu, China · Recruiting

  • Changzhou First People's Hospital

    Changzhou, Jiangsu, China · Recruiting

  • Yancheng First People's Hospital

    Yancheng, Jiangsu, China · Recruiting

  • Jiangsu University Affiliated Hospital

    Zhenjiang, Jiangsu, China · Recruiting

  • The First Affiliated Hospital of Gannan Medical College

    Ganzhou, Jiangxi, China · Recruiting

  • The First Bethune Hospital of Jilin University

    Changchun, Jilin, China · Recruiting

  • Panjin Liaoyou Gemstone Flower Hospital

    Panjin, Liaoning, China · Recruiting

Showing 40 of 59 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.